| Dr Benjamin Miller, DO | |
|
255 W Lucas St, Marengo, IA 52301-1331 | |
| (319) 741-6789 | |
| (319) 741-6791 |
| Full Name | Dr Benjamin Miller |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 255 W Lucas St, Marengo, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982991048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04362 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Keystone Home Health | Keystone, IA | Home health agency |
| Essence Of Life Hospice | Amana, IA | Hospice |
| Compass Memorial Healthcare | Marengo, IA | Hospital |
| Rose Haven Nursing Home | Marengo, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marengo Memorial Hospital | 0749199446 | 19 |
News Archive
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
"On Monday, April 15, USAID Administrator [Rajiv Shah] participated in a Twitter chat to answer ... questions on the proposed food aid reform in President Obama's 2014 proposed budget," Phillip Pollman, an intern with USAID, writes in the agency's "IMPACTblog."
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.
› Verified 5 days ago
| Entity Name | Marengo Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053368191 PECOS PAC ID: 0749199446 Enrollment ID: O20040318000643 |
News Archive
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
"On Monday, April 15, USAID Administrator [Rajiv Shah] participated in a Twitter chat to answer ... questions on the proposed food aid reform in President Obama's 2014 proposed budget," Phillip Pollman, an intern with USAID, writes in the agency's "IMPACTblog."
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin Miller, DO 255 W Lucas St, Marengo, IA 52301-1331 Ph: (319) 741-6789 | Dr Benjamin Miller, DO 255 W Lucas St, Marengo, IA 52301-1331 Ph: (319) 741-6789 |
News Archive
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
"On Monday, April 15, USAID Administrator [Rajiv Shah] participated in a Twitter chat to answer ... questions on the proposed food aid reform in President Obama's 2014 proposed budget," Phillip Pollman, an intern with USAID, writes in the agency's "IMPACTblog."
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.
› Verified 5 days ago
Philip E Mccune, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 255 W Lucas St, Marengo, IA 52301 Phone: 319-741-6789 Fax: 319-741-6791 | |
Dr. Mark B. Irland, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 W. May St., Marengo, IA 52301 Phone: 319-642-5543 Fax: 319-642-8068 | |
Tiffany Willis, Family Medicine Medicare: Medicare Enrolled Practice Location: 255 W Lucas St, Marengo, IA 52301 Phone: 319-642-5213 Fax: 319-642-3636 | |
Taylor Marie Felker, DNP, ARNP, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W May St, Marengo, IA 52301 Phone: 319-741-6789 |